A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in HER2-Positive Early Breast Cancer
CHEN Wei,XIA Su-jian*,LI He,LIANG Yong-qing,ZHANG Zhan
Chinese Pharmaceutical Journal ›› 2017, Vol. 52 ›› Issue (8) : 696-701.
A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in HER2-Positive Early Breast Cancer
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|